June 26, 2017
Strongbridge Biopharma plc Added to the Russell 3000® Index
Media
June 21, 2017
Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today
June 20, 2017
Onxeo successfully raises €15 Million with US and European investors
June 19, 2017
Nordic Nanovector to present to investors at the Citi European Healthcare Conference
June 19, 2017
Onxeo launches a capital increase by means of an accelerated book-build offering
June 14, 2017
Tisbury Pharmaceuticals Launches with a USD 32 Million Series A Financing to Develop First-in-class Therapeutics for Glaucoma
June 14, 2017
Single dose Betalutin® continues to show promising efficacy and safety in recurrent indolent NHL patients
June 14, 2017
GenSight Biologics reports long-term positive safety and visual acuity results at Week 96 in Phase I/II Study of GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
June 13, 2017
Strongbridge Biopharma plc to Participate in the JMP Securities Life Science Conference
June 12, 2017
CARMA Therapeutics Closes Initial Funding to Advance Chimeric Antigen Receptor Macrophages (CARMA) to Treat Solid Tumors
